Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Ned Tijdschr Geneeskd ; 150(25): 1373-9, 2006 Jun 24.
Artículo en Holandés | MEDLINE | ID: mdl-16841584

RESUMEN

Over the past 30 years, cardiovascular nuclear medicine has become an important diagnostic tool in patients with known and suspected coronary artery disease. Myocardial perfusion scintigraphy is indicated in: patients with suspected coronary artery disease and an intermediate likelihood of disease to detect myocardial ischemia, patients with a sustained myocardial infarction to assess myocardial viability, patients following revascularization for risk stratification, and coronary patients to assess prognosis. Gated SPECT myocardial perfusion imaging offers the potential of assessing left ventricular function and myocardial perfusion simultaneously. Information on left ventricular function and volumes significantly improves the diagnostic accuracy of myocardial perfusion imaging. The gated SPECT technique is a valuable tool for risk stratification because it offers the potential of assessing left ventricular function and volumes, which are both important prognostic parameters.


Asunto(s)
Enfermedades Cardiovasculares/diagnóstico por imagen , Técnicas de Diagnóstico Cardiovascular , Diagnóstico Diferencial , Humanos , Pronóstico , Tomografía Computarizada de Emisión de Fotón Único
2.
Eur J Surg Oncol ; 40(10): 1250-5, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24685336

RESUMEN

BACKGROUND: Multicentric breast cancer is often considered a contra-indication for sentinel lymph node (SLN) biopsy due to concerns with sensitivity and false negative rate. To assess SLN feasibility and accuracy in multicentric breast cancer, the multi-institutional SMMaC trial was conducted. METHODS: In this study 30 patients with multicentric breast cancer and a clinically negative axilla were prospectively included. Periareolar injection of radioisotope and blue dye was administered. In all patients SLN biopsy was validated by back-up completion axillary lymph node dissection. RESULTS: the SLN was successfully identified in 30 of 30 patients (identification rate 100%). The incidence of axillary metastases was 66.7% (20/30). The false negative rate was 0% (0/20) and the sensitivity was 100% (20/20). The negative predictive value was 100% (10/10). CONCLUSION: SLN biopsy in multicentric breast cancer seems feasible and accurate and should therefore be considered in patients with multicentric breast cancer and clinically negative axilla.


Asunto(s)
Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/patología , Carcinoma Lobular/patología , Escisión del Ganglio Linfático , Ganglios Linfáticos/patología , Neoplasias Primarias Múltiples/patología , Biopsia del Ganglio Linfático Centinela , Adulto , Anciano , Axila , Neoplasias de la Mama/cirugía , Carcinoma Ductal de Mama/cirugía , Carcinoma Lobular/cirugía , Colorantes , Reacciones Falso Negativas , Estudios de Factibilidad , Femenino , Humanos , Ganglios Linfáticos/cirugía , Mastectomía , Persona de Mediana Edad , Neoplasias Primarias Múltiples/cirugía , Compuestos de Organotecnecio , Estudios Prospectivos , Cintigrafía , Radiofármacos , Colorantes de Rosanilina
3.
Breast ; 23(2): 159-64, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24456968

RESUMEN

BACKGROUND: In breast cancer, sentinel node biopsy is considered the standard method to assess the lymph node status of the axilla. Preoperative identification of sentinel lymph nodes (SLN) is performed by injecting a radioactive tracer, followed by lymphoscintigraphy. In some patients there is a discrepancy between the number of lymphoscintigraphically identified sentinel nodes and the number of nodes found during surgery. We hypothesized that the inability to find peroperatively all the lymphoscintigraphically identified sentinel nodes, might lead to an increase in axillary recurrence because of positive SLNs not being removed. METHODS: Patients who underwent sentinel node biopsy between January 2000 and July 2010 were identified from a prospectively collected database. The number of lymphoscintigraphically and peroperatively identified sentinel nodes were reviewed and compared. Axillary recurrences were scored. RESULTS: 1368 patients underwent a SLN biopsy. Median follow up was 58.5 months (range 12-157). Patient and tumour characteristics showed no significant differences. In 139 patients (10.2%) the number of radioactive nodes found during surgery was less than preoperative scanning (group 1) and in 89.8% (N = 1229) there were equal or more peroperative nodes identified than seen lymphoscintigraphically (group 2). In group 1, 0/139 patients (0%) developed an axillary recurrence and in the second group this was 25/1229 (2.0%) respectively. No significant difference between groups regarding axillary recurrence, sentinel node status and distant metastasis was found. CONCLUSION: Axillary recurrence rate is not influenced by the inability to remove all sentinel nodes during surgery that have been identified preoperatively by scintigraphy.


Asunto(s)
Axila/patología , Neoplasias de la Mama/patología , Ganglios Linfáticos/patología , Metástasis Linfática/patología , Linfocintigrafia/métodos , Recurrencia Local de Neoplasia/patología , Biopsia del Ganglio Linfático Centinela/métodos , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Países Bajos , Estudios Prospectivos , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA